Effect of anti-IgE therapy in patients with peanut allergy. 2003

Effect of anti-IgE therapy in patients with peanut allergy.

Abstract

BACKGROUND:

Peanut-induced anaphylaxis is an IgE-mediated condition that is estimated to affect 1.5 million people and cause 50 to 100 deaths per year in the United States. TNX-901 is a humanized IgG1 monoclonal antibody against IgE that recognizes and masks an epitope in the CH3 region of IgE responsible for binding to the high-affinity Fc(epsilon) receptor on mast cells and basophils.

METHODS:

We conducted a double-blind, randomized, dose-ranging trial in 84 patients with a history of immediate hypersensitivity to peanut. Hypersensitivity was confirmed and the threshold dose of encapsulated peanut flour established by a double-blind, placebo-controlled oral food challenge at screening. Patients were randomly assigned in a 3:1 ratio to receive either TNX-901 (150, 300, or 450 mg) or placebo subcutaneously every four weeks for four doses. The patients underwent a final oral food challenge within two to four weeks after the fourth dose.

RESULTS:

From a mean base-line threshold of sensitivity of 178 to 436 mg of peanut flour in the various groups, the mean increases in the oral-food-challenge threshold were 710 mg in the placebo group, 913 mg in the group given 150 mg of TNX-901, 1650 mg in the group given 300 mg of TNX-901, and 2627 mg in the group given 450 mg of TNX-901 (P<0.001 for the comparison of the 450-mg dose with placebo, and P for trend with increasing dose <0.001). TNX-901 was well tolerated.

CONCLUSIONS:

A 450-mg dose of TNX-901 significantly and substantially increased the threshold of sensitivity to peanut on oral food challenge from a level equal to approximately half a peanut (178 mg) to one equal to almost nine peanuts (2805 mg), an effect that should translate into protection against most unintended ingestions of peanuts.

Copyright 2003 Massachusetts Medical Society

Link To:

Leung, D.Y., Sampson, H.A., Yunginger, J.W., Burks, A.W. Jr., Schneider, L.C., Wortel, C.H. et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003; 348: 986–993

http://www.ncbi.nlm.nih.gov/pubmed/12637608

http://www.nejm.org/doi/full/10.1056/NEJMoa022613#t=article

Site created by Food Allergy Parents like YOU ! … They said there were NO TREATMENTS for food allergy!